About Careers MedBlog Contact us

Simple Urine Test can Detect Severity of Bladder Cancer

by Kathy Jones on December 2, 2013 at 9:27 PM
Font : A-A+

 Simple Urine Test can Detect Severity of Bladder Cancer

A new study published in the British Journal of Cancer suggests that the severity of bladder cancer can be detected by carrying out a simple urine test.

Researchers led by Dr Douglas Ward, from the University of Birmingham, studied over 600 patients suffering from varying grades of bladder cancer and analyzed their tumors, measuring the levels of a specific protein, EpCAM, shed by the tumors and found that higher levels of the protein in urine coincided with a more aggressive form of cancer.


The researchers hope that their findings will allow doctors to provide a more personalized treatment for patients depending on the severity of their cancers.

"This protein could be used to help doctors to decide what the best course of investigation or treatment for the patients is, and may prevent unnecessary delays. We've known for some time that the protein EpCAM is released from some tumor cells but it wasn't clear whether it would be useful as a way to decide the best investigation and treatment for patients suspected of having bladder cancer. We are now planning further studies to test the benefits of urine biomarker testing to patients and the NHS", Dr Ward said.

Source: Medindia


Recommended Reading

Latest Cancer News

 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
Hope for Lethal Brain Tumors: Targeted Therapy Delays Glioma Progression
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Simple Urine Test can Detect Severity of Bladder Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests